Monoclonal gammopathy plus positive amyloid biopsy does not always equal AL amyloidosis

M. Hasib Sidiqi; Surendra Dasari; Ellen D. McPhail; Francis K. Buadi; Rahma Warsame; Martha Q. Lacy; David Dingli; Wilson I. Gonsalves; Prashant Kapoor; Taxiarchis Kourelis; Nelson Leung; Eli Muchtar; Martha Grogan; John A. Lust; Shaji Kumar; Robert A. Kyle; Vincent S. Rajkumar; Morie Gertz; Angela Dispenzieri

doi:10.1002/ajh.25440

Monoclonal gammopathy plus positive amyloid biopsy does not always equal AL amyloidosis

M. Hasib Sidiqi, Surendra Dasari, Ellen D. McPhail, Francis K. Buadi, Rahma Warsame, Martha Q. Lacy, David Dingli, Wilson I. Gonsalves, Prashant Kapoor, Taxiarchis Kourelis, Nelson Leung, Eli Muchtar, Martha Grogan, John A. Lust, Shaji Kumar, Robert A. Kyle, Vincent S. Rajkumar, Morie Gertz, Angela Dispenzieri

Research output: Contribution to journal › Letter › peer-review

10 Scopus citations

Original language	English (US)
Pages (from-to)	E141-E143
Journal	American journal of hematology
Volume	94
Issue number	5
DOIs	https://doi.org/10.1002/ajh.25440
State	Published - May 2019

ASJC Scopus subject areas

Hematology

Access to Document

10.1002/ajh.25440

Cite this

Sidiqi, M. H., Dasari, S., McPhail, E. D., Buadi, F. K., Warsame, R., Lacy, M. Q., Dingli, D., Gonsalves, W. I., Kapoor, P., Kourelis, T., Leung, N., Muchtar, E., Grogan, M., Lust, J. A., Kumar, S., Kyle, R. A., Rajkumar, V. S., Gertz, M., & Dispenzieri, A. (2019). Monoclonal gammopathy plus positive amyloid biopsy does not always equal AL amyloidosis. American journal of hematology, 94(5), E141-E143. https://doi.org/10.1002/ajh.25440

Sidiqi, MH, Dasari, S , McPhail, ED, Buadi, FK, Warsame, R, Lacy, MQ , Dingli, D , Gonsalves, WI , Kapoor, P , Kourelis, T, Leung, N, Muchtar, E, Grogan, M, Lust, JA, Kumar, S, Kyle, RA, Rajkumar, VS , Gertz, M & Dispenzieri, A 2019, 'Monoclonal gammopathy plus positive amyloid biopsy does not always equal AL amyloidosis', American journal of hematology, vol. 94, no. 5, pp. E141-E143. https://doi.org/10.1002/ajh.25440

@article{d72fa023ac574a2a896809931ae5a1d8,

title = "Monoclonal gammopathy plus positive amyloid biopsy does not always equal AL amyloidosis",

author = "Sidiqi, {M. Hasib} and Surendra Dasari and McPhail, {Ellen D.} and Buadi, {Francis K.} and Rahma Warsame and Lacy, {Martha Q.} and David Dingli and Gonsalves, {Wilson I.} and Prashant Kapoor and Taxiarchis Kourelis and Nelson Leung and Eli Muchtar and Martha Grogan and Lust, {John A.} and Shaji Kumar and Kyle, {Robert A.} and Rajkumar, {Vincent S.} and Morie Gertz and Angela Dispenzieri",

note = "Funding Information: M.A.G. received consultancy from Millenium and honoraria from Cel-gene, Millenium, Onyx, Novartis, SmithKline, Prothena, Ionis, and Amgen. S.K.K. received consultancy from Celgene, Millennium, Onyx, Janssen, and BMS and research funding from Celgene, Millennium, Novartis, Onyx AbbVie, Janssen, and BMS. M.Q.L. received research funding from Celgene. D.D. received research funding from Karyopharm Therapeutics, and Millenium Pharmaceuticals. P.K. received research funding from Takeda, Celgene, and Amgen. A.D. received research funding from Celgene, Millennium, Pfizer, and Janssen and travel grant from Pfizer. The remaining authors declare no competing financial interests.",

year = "2019",

month = may,

doi = "10.1002/ajh.25440",

language = "English (US)",

volume = "94",

pages = "E141--E143",

journal = "American journal of hematology",

issn = "0361-8609",

publisher = "Wiley-Liss Inc.",

number = "5",

}

TY - JOUR

T1 - Monoclonal gammopathy plus positive amyloid biopsy does not always equal AL amyloidosis

AU - Sidiqi, M. Hasib

AU - Dasari, Surendra

AU - McPhail, Ellen D.

AU - Buadi, Francis K.

AU - Warsame, Rahma

AU - Lacy, Martha Q.

AU - Dingli, David

AU - Gonsalves, Wilson I.

AU - Kapoor, Prashant

AU - Kourelis, Taxiarchis

AU - Leung, Nelson

AU - Muchtar, Eli

AU - Grogan, Martha

AU - Lust, John A.

AU - Kumar, Shaji

AU - Kyle, Robert A.

AU - Rajkumar, Vincent S.

AU - Gertz, Morie

AU - Dispenzieri, Angela

N1 - Funding Information: M.A.G. received consultancy from Millenium and honoraria from Cel-gene, Millenium, Onyx, Novartis, SmithKline, Prothena, Ionis, and Amgen. S.K.K. received consultancy from Celgene, Millennium, Onyx, Janssen, and BMS and research funding from Celgene, Millennium, Novartis, Onyx AbbVie, Janssen, and BMS. M.Q.L. received research funding from Celgene. D.D. received research funding from Karyopharm Therapeutics, and Millenium Pharmaceuticals. P.K. received research funding from Takeda, Celgene, and Amgen. A.D. received research funding from Celgene, Millennium, Pfizer, and Janssen and travel grant from Pfizer. The remaining authors declare no competing financial interests.

PY - 2019/5

Y1 - 2019/5

UR - http://www.scopus.com/inward/record.url?scp=85062352160&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062352160&partnerID=8YFLogxK

U2 - 10.1002/ajh.25440

DO - 10.1002/ajh.25440

M3 - Letter

C2 - 30773682

AN - SCOPUS:85062352160

SN - 0361-8609

VL - 94

SP - E141-E143

JO - American journal of hematology

JF - American journal of hematology

IS - 5

ER -

Monoclonal gammopathy plus positive amyloid biopsy does not always equal AL amyloidosis

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this